New York State Common Retirement Fund Sells 77,726 Shares of Integer Holdings Co. (NYSE:ITGR)

New York State Common Retirement Fund lessened its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 38.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 125,184 shares of the medical equipment provider's stock after selling 77,726 shares during the quarter. New York State Common Retirement Fund owned about 0.38% of Integer worth $12,403,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in ITGR. Fuller & Thaler Asset Management Inc. increased its stake in Integer by 497.0% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider's stock valued at $42,065,000 after buying an additional 446,508 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider's stock valued at $128,041,000 after acquiring an additional 133,898 shares in the last quarter. FMR LLC increased its stake in shares of Integer by 12.8% during the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider's stock worth $67,759,000 after acquiring an additional 97,851 shares during the period. Envestnet Asset Management Inc. raised its holdings in Integer by 50.7% during the third quarter. Envestnet Asset Management Inc. now owns 254,904 shares of the medical equipment provider's stock worth $19,992,000 after purchasing an additional 85,711 shares in the last quarter. Finally, Congress Asset Management Co. MA lifted its position in Integer by 24.8% in the third quarter. Congress Asset Management Co. MA now owns 374,748 shares of the medical equipment provider's stock valued at $29,391,000 after purchasing an additional 74,510 shares during the period. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ITGR shares. Benchmark restated a "buy" rating and issued a $130.00 price objective on shares of Integer in a research report on Friday, April 26th. KeyCorp raised their price objective on shares of Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a research report on Tuesday, April 9th. Bank of America raised shares of Integer from a "neutral" rating to a "buy" rating and increased their target price for the company from $105.00 to $135.00 in a report on Monday, April 15th. Finally, CL King assumed coverage on shares of Integer in a report on Thursday, March 14th. They issued a "buy" rating and a $137.00 target price for the company. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $120.50.

Integer Trading Down 1.7 %

Shares of ITGR traded down $1.86 during mid-day trading on Wednesday, reaching $109.77. The company had a trading volume of 274,270 shares, compared to its average volume of 345,695. The stock has a market cap of $3.68 billion, a price-to-earnings ratio of 38.62, a price-to-earnings-growth ratio of 1.69 and a beta of 1.10. The firm has a fifty day simple moving average of $113.64 and a 200-day simple moving average of $100.61. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $123.99. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer's revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business earned $0.87 EPS. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.27 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.